Parra-Espejel Emiliano de Jesús, Hipólito-Jiménez Samara Jennifer, Galicia González Melissa Daniela, Montes Rojas Diana, Llera-Rojas Viridiana Gisela, Velázquez-Moyado Josué A
Facultad de Química, Departamento de Farmacia, Universidad Nacional Autónoma de México, Ciudad Universitaria, Coyoacán, Mexico City, 04510, México.
Unidad de Servicios y Desarrollo Farmacéutico, Facultad de Química, Universidad Nacional Autónoma de México, Ciudad Universitaria, Coyoacán, Mexico City, 04510, México.
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jun 12. doi: 10.1007/s00210-025-04331-4.
In Mexico, the use of infusions from Eysenhardtia polystachya in traditional medicine as a treatment for chronic inflammatory pathologies, such as urinary disorders, diabetes, and oxidative stress has been studied in the search for bioactive molecules with pharmacological properties. In this study, a methanolic extract was obtained from which Coatline B and Matlaline molecules were isolated and identified. Their pharmacological activity was subsequently evaluated as potential nephroprotective agents using both in vivo and in vitro models of acute kidney injury (AKI). The experimental results indicated that the Coatline B and Matlaline compounds exhibit antioxidant activity and play a role in nitric oxide (NO) and hydrogen sulfide (HS) regulation pathways as mediators of inflammation in renal tissue. Consequently, their use as prophylactic agents in a model of AKI reduces renal tissue damage and prevents a severe decline in kidney function.
在墨西哥,人们研究了多穗艾森豆在传统医学中用于治疗慢性炎症性疾病(如泌尿系统疾病、糖尿病和氧化应激)的浸液,以寻找具有药理特性的生物活性分子。在这项研究中,获得了一种甲醇提取物,并从中分离和鉴定出了Coatline B和Matlaline分子。随后,使用急性肾损伤(AKI)的体内和体外模型,将它们作为潜在的肾保护剂进行了药理活性评估。实验结果表明,Coatline B和Matlaline化合物具有抗氧化活性,并在作为肾组织炎症介质的一氧化氮(NO)和硫化氢(HS)调节途径中发挥作用。因此,在AKI模型中,将它们用作预防剂可减少肾组织损伤,并防止肾功能严重下降。